Partnership with Organon to expand women's health solutions and access in Myanmar.
This partnership addresses critical unmet needs in women's health in Myanmar, a region with significant challenges in reproductive healthcare. By combining Organon's specialized products with Zuellig Pharma's distribution and educational expertise, the initiative aims to empower women, reduce maternal health risks, and contribute to broader public health improvements.
The focus on Myanmar highlights Zuellig Pharma's commitment to improving healthcare access in Southeast Asia's developing markets. This initiative is crucial for addressing specific health disparities faced by women in the region, promoting reproductive autonomy, and fostering healthier communities.
The collaboration aims to expand women's health access in Myanmar.
It focuses on reproductive health and education initiatives.
Zuellig Pharma and Organon formed a partnership.
The collaboration aims to expand women's health access in Myanmar.
It focuses on reproductive health and education initiatives.
Zuellig Pharma and Organon have formed a strategic partnership to expand access to women's health solutions in Myanmar. The collaboration focuses on addressing unintended pregnancies and improving reproductive health through broad distribution of products and comprehensive education initiatives, aiming to enhance women's well-being in the country.
Sign in to save notes on signals.
Sign In